![John Lunger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Lunger
Inga fler pågående positioner
Förmögenhet: 1 776 $ per 2026-05-31
Profil
John Lunger formerly worked at Genocea Biosciences, Inc., as Independent Director, Merrimack Pharmaceuticals, Inc., as Head-Supply Chain & Commercial Product Supply, and Adaptimmune Therapeutics Plc, as Chief Patient Supply Officer from 2019 to 2025.
Mr. Lunger received his undergraduate degree from United States Naval Academy and Masters Business Admin degree from The University of Chicago Booth School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-04-11 | 1 025 340 ( 0,06 % ) | 1 025 $ | 2026-05-31 | |
Lipella Pharmaceuticals, Inc.
 Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes 0,16 % | 2025-01-17 | 7 510 ( 0,16 % ) | 751 $ | 2026-05-31 |
Tidigare kända positioner av John Lunger
| Företag | Position | Slut |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Företagsledare/Principal | 2025-08-29 |
| MERRIMACK PHARMACEUTICALS | Företagsledare/Principal | - |
| GENOCEA BIOSCIENCES, INC. | Direktör/Styrelseledamot | - |
John Lungers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
13
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
United States Naval Academy
 United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
